Cambridge, MA · Founded 2013 · Privately Held (backing)
Developer of small-molecule drugs intended to treat autoimmune and inflammatory diseases. Artax Biopharma is based in Cambridge, MA and was founded in 2013. Its last reported valuation was $58 million in May 2022. It has raised $51.5 million across 8 recorded rounds; the latest was a $19 million early-stage round in Jul 2024.
Last reported valuation
$58.0M
Oct 2026
Priced at
—
Total raised
$51.5M
Last round
Early Stage VC
Jul 2024
Team — not yet on record
No current team members for Artax Biopharma are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Artax Biopharma with a free account
·Watch Artax Biopharma: the Monday email on marks, rounds and moves
